- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05873543
El efecto de un programa de rehabilitación cardíaca híbrido asistido por teléfono inteligente en pacientes con insuficiencia cardíaca. (SHCR-HF)
The aim of this randomized controlled trial is to compare the impact of a case manager-led smartphone-assisted hybrid cardiac rehabilitation program with usual care in patients with HF. Participants will undergo a 12-week program led by a case manager and assisted by a smartphone. The study aims to answer two main questions:
- Is the novel cardiac rehabilitation model feasible for patients with HF?
- Does the intervention group show a significant improvement in exercise capacity and adherence compared to the usual care group?
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Hung-Jui Chuang, MD
- Número de teléfono: 67034 00886-2-23123456
- Correo electrónico: rexintwo@gmail.com
Ubicaciones de estudio
-
-
-
Taipei, Taiwán
- Reclutamiento
- Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
-
Contacto:
- Hung-Jui Chuang, MD
- Número de teléfono: 67034 00886-2-23123456
- Correo electrónico: rexintwo@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients with heart failure between the ages of 18 and 80 years old.
- NYHA (New York Heart Association) functional classification of 1 to 3.
- Patients must be in a stable condition and under outpatient follow-up.
Exclusion Criteria:
- Patients who have contraindications for exercise according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
- Patients who are unable to complete cardiopulmonary exercise testing.
- Patients who are unable to follow verbal instructions.
- Patients who are unable to walk independently or pedal a stationary bicycle.
- Patients who are unable to use communication app on a smartphone.
- Patients who already engage in physical activity exceeding the recommended moderate intensity of 150 minutes per week or are currently participating in cardiac rehabilitation.
- Patients who do not provide consent to participate in the trial.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: smartphone-assisted hybrid cardiac rehabilitation (SHCR)
Participants receive a 12-wk case manager-led smartphone-assisted hybrid cardiac rehabilitation with follow-up at 12 week and 6 months. |
The 12-week case manager-led SHCR program includes:
|
|
Sin intervención: Usual care
Participants receive usual care including general education and exercise suggestion. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change of peak oxygen uptake
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 6 months. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Change of 6 minute walking test
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
6 minute walking test will be performed before intervention, at 12 weeks (post-intervention), and at 6 months. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Adherence to prescribed exercise
Periodo de tiempo: 12 weeks(post-intervention)
|
We will evaluate the percentage of completed prescribed exercises at 12 weeks. |
12 weeks(post-intervention)
|
|
Evaluation of Quality of life
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The investigators will assess the change in 36-Item Short Form Survey(SF-36). |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Depression
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Anxiety
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Evaluation of physical activity
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The investigators will assess the change in physical activity using International Physical Activity Questionnaire(IPAQ) Taiwan version. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Evaluation of grip strength
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Evaluation of frailty
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The investigators will evaluate the change in the Clinical Frailty Scale, which ranges from 1 to 9. Higher scores represent greater illness. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Blood test: Total cholesterol
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The Total cholesterol will be tested in the laboratory. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Blood test: LDL
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The LDL will be tested in the laboratory. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Blood test: HDL
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The HDL will be tested in the laboratory. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Blood test: Triglyceride
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The Triglyceride will be tested in the laboratory. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
|
Blood test: NT-proBNP
Periodo de tiempo: at baseline, 12 weeks(post-intervention), and 6 months.
|
The NT-proBNP will be tested in the laboratory. |
at baseline, 12 weeks(post-intervention), and 6 months.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Hung-Jui Chuang, MD, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 202302009RINC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .